5.00
전일 마감가:
$5.03
열려 있는:
$5.03
하루 거래량:
401.97K
Relative Volume:
0.47
시가총액:
$634.29M
수익:
$433.14M
순이익/손실:
$4.95M
주가수익비율:
140.06
EPS:
0.0357
순현금흐름:
$6.55M
1주 성능:
-2.91%
1개월 성능:
+10.38%
6개월 성능:
-16.81%
1년 성능:
+89.39%
Organogenesis Holdings Inc Stock (ORGO) Company Profile
명칭
Organogenesis Holdings Inc
전화
781-575-0775
주소
85 DAN ROAD, CANTON, MA
ORGO을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ORGO
Organogenesis Holdings Inc
|
5.00 | 638.09M | 433.14M | 4.95M | 6.55M | 0.0357 |
![]()
ZTS
Zoetis Inc
|
153.32 | 67.90B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.40 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.80 | 44.04B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.20B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
400.52 | 17.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-06-28 | 개시 | Lake Street | Buy |
2024-02-07 | 개시 | Cantor Fitzgerald | Overweight |
2023-06-15 | 개시 | Morgan Stanley | Equal-Weight |
2023-05-24 | 업그레이드 | BTIG Research | Neutral → Buy |
2022-11-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
2022-08-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2020-01-10 | 개시 | SVB Leerink | Outperform |
2019-08-26 | 재개 | Credit Suisse | Outperform |
2019-05-02 | 개시 | Credit Suisse | Outperform |
2019-04-17 | 개시 | Oppenheimer | Outperform |
2019-04-11 | 개시 | SunTrust | Buy |
모두보기
Organogenesis Holdings Inc 주식(ORGO)의 최신 뉴스
Organogenesis Holdings Inc. stock outlook for YEAREarnings Miss & Advanced Technical Signal Analysis - Newser
Using R and stats models for Organogenesis Holdings Inc. forecastingQuarterly Trade Summary & Daily Price Action Insights - Newser
Can momentum traders help lift Organogenesis Holdings Inc.Bear Alert & Risk Controlled Daily Plans - Newser
Will Organogenesis Holdings Inc. outperform during market ralliesWeekly Trade Recap & Safe Capital Growth Tips - خودرو بانک
How to integrate Organogenesis Holdings Inc. into portfolio analysis tools - Newser
How much upside does Organogenesis Holdings Inc. haveJuly 2025 Earnings & Safe Capital Investment Plans - خودرو بانک
Will Organogenesis Holdings Inc. see short term momentumJuly 2025 Final Week & Fast Gain Stock Tips - Newser
News impact scoring models applied to Organogenesis Holdings Inc.July 2025 Reactions & Daily Profit Focused Screening - Newser
Will Organogenesis Holdings Inc. rebound enough to break evenGap Up & High Accuracy Investment Signals - Newser
Is Organogenesis Holdings Inc. reversing from oversold territory2025 Price Momentum & AI Enhanced Trading Alerts - Newser
Analyzing recovery setups for Organogenesis Holdings Inc. investorsJuly 2025 Setups & Verified Technical Signals - Newser
Is Organogenesis Holdings Inc. stock poised for growthEntry Point & Long-Term Capital Growth Strategies - Newser
Organogenesis at Cantor Global Healthcare Conference: Strategic Shifts Ahead - Investing.com
Risk Report: Is Organogenesis Holdings Inc. a turnaround storyCEO Change & Reliable Breakout Forecasts - خودرو بانک
Backtesting results for Organogenesis Holdings Inc. trading strategiesIndex Update & Low Risk High Reward Ideas - Newser
Is Organogenesis Holdings Inc. forming a bottoming baseJuly 2025 Gainers & Weekly Sector Rotation Insights - Newser
Does Organogenesis Holdings Inc. outperform in volatile markets2025 Biggest Moves & Entry Point Confirmation Signals - خودرو بانک
Risk adjusted return profile for Organogenesis Holdings Inc. analyzedGDP Growth & Verified High Yield Trade Plans - Newser
How did ORGO's revenue and expenses shift in Q4 2024? - AInvest
Technical analysis overview for Organogenesis Holdings Inc. stockExit Point & Daily Stock Trend Reports - Newser
Can swing trading help recover from Organogenesis Holdings Inc. lossesInsider Buying & Daily Stock Trend Watchlist - Newser
Is Organogenesis Holdings Inc. still worth holding after the dipWeekly Trade Summary & AI Enhanced Trade Execution Alerts - Newser
Relative strength of Organogenesis Holdings Inc. in sector analysisPrice Action & Low Drawdown Momentum Ideas - Newser
What technical models suggest about Organogenesis Holdings Inc.’s comeback2025 Market Outlook & Verified Swing Trading Watchlist - Newser
Visual trend scoring systems applied to Organogenesis Holdings Inc.Quarterly Growth Report & Stepwise Trade Signal Guides - Newser
Using data filters to optimize entry into Organogenesis Holdings Inc.Market Volume Report & Weekly Chart Analysis and Trade Guides - Newser
Can Organogenesis Holdings Inc. keep up with sector leadersPortfolio Performance Report & Fast Momentum Entry Tips - خودرو بانک
Can Organogenesis Holdings Inc. deliver consistent dividendsJuly 2025 Technicals & Trade Opportunity Analysis Reports - خودرو بانک
Published on: 2025-09-01 03:01:18 - Newser
What candlestick patterns are forming on Organogenesis Holdings Inc.July 2025 Outlook & AI Based Buy/Sell Signal Reports - Newser
News impact scoring models applied to Organogenesis Holdings Inc2025 Earnings Surprises & Stepwise Trade Signal Implementation - Newser
Organogenesis: Transformational Changes Taking Shape (NASDAQ:ORGO) - Seeking Alpha
Reversal indicators forming on Organogenesis Holdings Inc. stockWeekly Earnings Recap & Safe Entry Momentum Tips - Newser
Organogenesis Holdings Inc (ORGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Organogenesis Holdings Inc 주식 (ORGO) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Freedman Lori | Chief Admin. and Legal Officer |
Jun 05 '25 |
Buy |
2.91 |
142,379 |
413,625 |
837,437 |
Freedman Lori | Chief Admin. and Legal Officer |
Jun 04 '25 |
Buy |
2.82 |
100,863 |
284,716 |
695,058 |
Freedman Lori | Chief Admin. and Legal Officer |
Jun 06 '25 |
Buy |
2.99 |
9,022 |
26,949 |
846,459 |
자본화:
|
볼륨(24시간):